These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35796893)

  • 1. Tumor suppressor LHPP suppresses cell proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma cell lines.
    Ma L; Sun H; Xu X; Chen Y; Zhang L; Li S; Tang L
    J Physiol Biochem; 2022 Nov; 78(4):807-817. PubMed ID: 35796893
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Liao L; Duan D; Liu Y; Chen L
    Cell Cycle; 2020 Jul; 19(14):1846-1854. PubMed ID: 32578511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma.
    Chao X; Zhang W; Wu J; Feng X; Shi H; Zhao L; Shen H; Jiang C
    Biomed Res Int; 2021; 2021():1971048. PubMed ID: 34485511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of LHPP by saRNA inhibited hepatocellular cancer cell proliferation and xenograft tumor growth.
    Bi CQ; Kang T; Qian YK; Kang M; Zeng XH; Li LC
    PLoS One; 2024; 19(5):e0299522. PubMed ID: 38696452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LHPP suppresses tumorigenesis of intrahepatic cholangiocarcinoma by inhibiting the TGFβ/smad signaling pathway.
    Wang D; Ning Z; Zhu Z; Zhang C; Wang P; Meng Z
    Int J Biochem Cell Biol; 2021 Mar; 132():105845. PubMed ID: 33401010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three LHPP gene-targeting co-expressed microRNAs (microRNA-765, microRNA-21, and microRNA-144) promote proliferation, epithelial-mesenchymal transition, invasion, and are independent prognostic biomarkers in renal cell carcinomas patients.
    Meng K; Li Z; Cui X
    J Clin Lab Anal; 2021 Dec; 35(12):e24077. PubMed ID: 34699621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
    J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIN17 promotes cell migration and invasion through stimulating the TGF-β/Smad2 pathway in hepatocellular carcinoma.
    Dai Z; Huang Q; Huang X; Zhu C; Zahid KR; Liu T; Li Q; Wu C; Peng M; Xiao X; Raza U; Yu N; Zeng T
    Mol Carcinog; 2023 Mar; 62(3):369-384. PubMed ID: 36468848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LHPP suppresses proliferation, migration, and invasion in hepatocellular carcinoma and pancreatic cancer by inhibiting EGFR signaling pathway.
    Zhu H; Song C; Li J; Liu Q; Liu M; Fu L
    Med Oncol; 2023 Jul; 40(9):257. PubMed ID: 37522936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
    Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LHPP suppresses bladder cancer cell proliferation and growth via inactivating AKT/p65 signaling pathway.
    Li Y; Zhang X; Zhou X; Zhang X
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MESP1-knockdown inhibits the proliferation and epithelial mesenchymal transition of hepatocellular carcinoma and enhances the tumor-suppressive effect of 5-fluorouracil.
    Ji S; Xu M; Cai C; He X
    Biochem Biophys Res Commun; 2023 Aug; 670():1-11. PubMed ID: 37271034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC4 mediated LHPP deacetylation enhances its destabilization and promotes the proliferation and metastasis of nasopharyngeal carcinoma.
    Sun X; Zhang K; Peng X; Zhou P; Qu C; Yang L; Shen L
    Cancer Lett; 2023 May; 562():216158. PubMed ID: 37023940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway.
    Hou B; Li W; Li J; Ma J; Xia P; Liu Z; Zeng Q; Zhang X; Chang D
    Oncol Rep; 2020 Feb; 43(2):536-548. PubMed ID: 31894339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rce1 suppresses invasion and metastasis of hepatocellular carcinoma via epithelial-mesenchymal transition induced by the TGF-β1/H-Ras signaling pathway.
    Ma C; Yang Y; Xu L; Tu W; Chen F; Wang J
    J Cell Physiol; 2020 Mar; 235(3):2506-2520. PubMed ID: 31506952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β/catenin and TGF/β-EMT signaling pathways.
    Liu Z; Zhang Y; Xu Z
    J BUON; 2018; 23(1):188-192. PubMed ID: 29552782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six2 is negatively correlated with prognosis and facilitates epithelial-mesenchymal transition via TGF-β/Smad signal pathway in hepatocellular carcinoma.
    Wan ZH; Ma YH; Jiang TY; Lin YK; Shi YY; Tan YX; Dong LW; Wang HY
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):525-531. PubMed ID: 31564506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.